Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q2 2025
Institutional positions in Forte Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +4 vs. Q1 2025
- Shares held
- 10.1M
- +4.90M (+94.8%) vs. Q1 2025
- Total value
- $130.4M
- +$90.1M (+223.1%) vs. Q1 2025
- New holders
- 8
- 16 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $13 | 0.00% | −526−99.8% | Reduced |
| Wells Fargo & Company | 2 | $26 | 0.00% | +2 | New |
| REAP Financial Group, LLC | 3 | $39 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 8 | $103 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 12 | $155 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 55 | $711 | 0.00% | +9+19.6% | Added |
| Group One Trading, L.P. | 104 | $1.34K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 151 | $1.95K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 157 | $2.03K | 0.00% | +2+1.3% | Added |
| Private Trust Co NA | 192 | $2.48K | 0.00% | +150+357.1% | Added |
| Garde Capital, Inc. | 3,960 | $51.2K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 9,234 | $119.0K | 0.00% | +5,892+176.3% | Added |
| Quest Partners LLC | 16,897 | $218.5K | 0.02% | +12,680+300.7% | Added |
| Envestnet Asset Management Inc | 18,856 | $243.8K | 0.00% | +18,856 | New |
| BlackRock, Inc. | 33,695 | $435.7K | 0.00% | +26,892+395.3% | Added |
| Mink Brook Asset Management LLC | 38,893 | $502.9K | 0.44% | +38,893 | New |
| Boothbay Fund Management, LLC | 58,637 | $758.2K | 0.02% | −30,554−34.3% | Reduced |
| Geode Capital Management, LLC | 64,110 | $829.1K | 0.00% | +4,028+6.7% | Added |
| Perceptive Advisors LLC | 68,192 | $881.7K | 0.03% | +68,192 | New |
| Millennium Management LLC | 72,116 | $932.5K | 0.00% | +57,511+393.8% | Added |
| Heights Capital Management, Inc | 143,033 | $1.85M | 0.58% | +143,033 | New |
| AWM Investment Company, Inc. | 261,821 | $3.39M | 0.38% | +125,000+91.4% | Added |
| Woodline Partners LP | 331,987 | $4.29M | 0.02% | +127,165+62.1% | Added |
| Adage Capital Partners GP, L.L.C. | 333,333 | $4.31M | 0.01% | +333,333 | New |
| Ikarian Capital, LLC | 476,443 | $6.16M | 2.04% | −132,782−21.8% | Reduced |
| Vanguard Group Inc | 486,919 | $6.30M | 0.00% | +397,968+447.4% | Added |
| Sphera Funds Management Ltd. | 495,109 | $6.40M | 1.67% | +495,109 | New |
| Cable Car Capital LLC | 500,000 | $6.46M | 2.80% | +280,396+127.7% | Added |
| BVF Inc | 588,344 | $7.61M | 0.27% | −5,938−1.0% | Reduced |
| Tybourne Capital Management (HK) Ltd | 786,647 | $10.2M | 29.45% | +166,666+26.9% | Added |
| Federated Hermes, Inc. | 1,072,233 | $13.9M | 0.03% | +1,072,233 | New |
| OrbiMed Advisors LLC | 1,196,955 | $15.5M | 0.39% | +603,867+101.8% | Added |
| Janus Henderson Group PLC | 1,394,852 | $18.3M | 0.01% | +474,852+51.6% | Added |
| Fred Alger Management, LLC | 1,618,649 | $20.9M | 0.09% | +708,040+77.8% | Added |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −70,429−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −18,469−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,792−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |